VRDN
Viridian Therapeutics, Inc. · Healthcare
Fairmount Funds Management LLC bought $10.0M of Viridian Therapeutics, Inc.
10% owner
Bought$9,999,979
$23.50Price
425,531Shares
+45%Stake
What VRDN did for a copier
- $1,000 copied at Mon, Aug 22 open, $23.82
- $872
- S&P 500, same days
- −9.0%
Measured over 30 trading days, to the Oct 4 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −9.8% against the S&P 500, and 6 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 17. Filed Fri, Aug 19, 4:32 PM ET, after the close. Returns use the Aug 22 open and the Oct 4 close. Not investment advice.